GlassScriptPhysician profile
Brian M Granek
NPI 1124027248
$4,375.36
in general payments reported to CMS, 2019-2025
14 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $1,191 · 2021: $210 · 2022: $448 · 2023: $957 · 2024: $164 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847 · Consulting Fee: $846 · Entertainment: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.48 |
| Consulting Fee | $845.93 |
| Entertainment | $444.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,978.91 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,321.76 | 2019-2025 | Acrysof Iq Panoptix Uv Iol, Total30, Precision 1 |
| Optos, INC. | $580.72 | 2022-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $70.40 | 2022-2023 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $69.18 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $56.78 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $53.09 | 2020-2021 | |
| Coopervision INC. | $46.40 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $44.60 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $39.60 | 2024-2025 | Miebo, Xiidra, Infuse |
| Sun Pharmaceutical Industries INC. | $32.90 | 2023 | Cequa |
| Alcon Research LLC | $32.50 | 2019 | |
| Oasis Medical, INC. | $25.00 | 2025 | Oasis Tears |
| Sight Sciences, INC. | $23.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Granek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.